InnoCare Pharma Stock Drops As Revenue Surges 88%, Eli Lilly Deal Expands Global Reach
One daysingle sourceOne outlet reported this, once - no second voice in this corpus.
All 1 reports on Tue, 27 October 2026
What it is about
Eli LillyInnocare PharmaNational Reimbursement Drug ListClinical Development UpdatesChinaBeijing, Beijing, China
Who published it, and when
How it spread - 1 original report
Tue, 27 October 2026
1 report- rttnews.com12:15first to report
InnoCare Pharma reported an 88.2% rise in nine-month 2026 revenue to RMB 2.1 billion, with net profit reaching RMB 648.3 million. Drug sales grew 41.5%, while an Eli Lilly collaboration worth up to $3.